부산대학교 도서관

2021; 21: 427. doi:10.1186/s12884-021-03928-w 11 Smati S, Mahot P, Bourdiol A, Ploteau S, Hadjadj S, Cariou B. Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection. Euglycemic diabetic ketoacidosis and COVID-19: A combination to foresee in pregnancy Diabetic ketoacidosis (DKA) is a serious complication of diabetes, becoming a life-threatening event to both the mother and the fetus.1 Euglycemic diabetic ketoacidosis (eu-DKA) is defined by a biochemical triad: blood glucose levels below 200 mg/dL, increased anion gap metabolic acidosis, and ketonemia.2,3 Eu-DKA is extremely rare in obstetric practice4-6 and requires a high degree of suspicion for diagnosis.7 COVID-19 infection may cause ketosis or ketoacidosis in the general population and can also induce DKA for those with diabetes.8 Diabetes does not seem to increase the risk of COVID-19 occurring but is more frequent in patients with severe COVID-19.9 Very few cases of eu-DKA have been reported in pregnant women with COVID-19.10 We present the case of a 29-year-old woman who is obese (BMI 31.5 kg/m SP 2 sp ), with gestational diabetes diagnosed at 27 weeks of gestation (initial glycosylated hemoglobin [HbA1c] 5.9%) and suboptimal metabolic control. [Extracted from the article]